Published in Carcinogenesis on January 01, 2000
Hepatotoxicity induced by cyproterone acetate: a report of three cases. World J Gastroenterol (2006) 1.00
Primary hepatocyte culture in collagen gel mixture and collagen sandwich. World J Gastroenterol (2004) 0.90
New cellular tools reveal complex epithelial-mesenchymal interactions in hepatocarcinogenesis. Br J Cancer (2008) 0.85
Induction of apoptosis in mouse liver adenoma and carcinoma in vivo by transforming growth factor-beta1. J Cancer Res Clin Oncol (2003) 0.78
Phenobarbital induces alterations in the proteome of hepatocytes and mesenchymal cells of rat livers. PLoS One (2013) 0.76
Inherent growth advantage of (pre)malignant hepatocytes associated with nuclear translocation of pro-transforming growth factor alpha. Br J Cancer (2004) 0.75
In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatology (1995) 3.67
Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1. Proc Natl Acad Sci U S A (1992) 2.54
Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats. Carcinogenesis (1990) 2.00
Programmed cell death (PCD). Apoptosis, autophagic PCD, or others? Ann N Y Acad Sci (2000) 1.93
Cell death by apoptosis and its protective role against disease. Trends Pharmacol Sci (1992) 1.90
Hepatocarcinogenic potential of di(2-ethylhexyl)phthalate in rodents and its implications on human risk. Crit Rev Toxicol (1996) 1.51
Induction of liver growth by xenobiotic compounds and other stimuli. CRC Crit Rev Toxicol (1974) 1.29
Condensation of the chromatin at the membrane of an apoptotic nucleus is not associated with activation of an endonuclease. J Cell Sci (1993) 1.25
Single cell gel electrophoresis assay: a new technique for human biomonitoring studies. Mutat Res (2000) 1.25
Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters. Carcinogenesis (1984) 1.24
Effect of transforming growth factor beta on cell death of cultured rat hepatocytes. Cancer Res (1991) 1.20
The Fas-induced apoptosis analyzed by high throughput proteome analysis. J Biol Chem (2000) 1.20
Khat (Catha edulis) consumption causes genotoxic effects in humans. Int J Cancer (2001) 1.19
Food restriction eliminates preneoplastic cells through apoptosis and antagonizes carcinogenesis in rat liver. Proc Natl Acad Sci U S A (1994) 1.19
Inherent increase of apoptosis in liver tumors: implications for carcinogenesis and tumor regression. Hepatology (1997) 1.17
Transforming growth factor-beta 1 as a signal for induction of cell death by apoptosis. Br J Cancer (1993) 1.16
Apoptosis is induced by transforming growth factor-beta 1 within 5 hours in regressing liver without significant fragmentation of the DNA. Hepatology (1993) 1.13
FGF5 as an oncogenic factor in human glioblastoma multiforme: autocrine and paracrine activities. Oncogene (2008) 1.11
Fibroblast growth factor receptor 3-IIIc mediates colorectal cancer growth and migration. Br J Cancer (2010) 1.09
Tumor promotion in the liver. Arch Toxicol (1985) 1.08
Use of metabolically competent human hepatoma cells for the detection of mutagens and antimutagens. Mutat Res (1998) 1.06
Impaired Ras membrane association and activation in PPARalpha knockout mice after partial hepatectomy. Am J Physiol Gastrointest Liver Physiol (2002) 1.00
Biology of transforming growth factor beta in hepatocarcinogenesis. Microsc Res Tech (2001) 0.99
Quantitative histological and histochemical studies on the occurrence and stages of controlled cell death (apoptosis) during regression of rat liver hyperplasia. Virchows Arch B Cell Pathol Incl Mol Pathol (1985) 0.99
Concepts of cell death and application to carcinogenesis. Toxicol Pathol (1997) 0.99
Genotoxic effects of crude juices from Brassica vegetables and juices and extracts from phytopharmaceutical preparations and spices of cruciferous plants origin in bacterial and mammalian cells. Chem Biol Interact (1996) 0.99
Adaptive responses of rat liver to the gestagen and anti-androgen cyproterone acetate and other inducers. II. Induction of growth. Chem Biol Interact (1980) 0.98
Induction of apoptosis in cultured hepatocytes and in the regressing liver by transforming growth factor-beta 1 occurs without activation of an endonuclease. Toxicol Lett (1992) 0.97
Role of active cell death (apoptosis) in multi-stage carcinogenesis. Toxicol Lett (1995) 0.96
Genotoxic effects of benzyl isothiocyanate, a natural chemopreventive agent. Mutagenesis (1999) 0.94
Promotion of spontaneous preneoplastic cells in rat liver as a possible explanation of tumor production by nonmutagenic compounds. Cancer Res (1983) 0.94
Enhanced proliferation of putative preneoplastic cells in rat liver following treatment with the tumor promoters phenobarbital, hexachlorocyclohexane, steroid compounds, and nafenopin. Cancer Res (1981) 0.93
Influence of the route of sensitization on local and systemic immune responses in a murine model of type I allergy. Clin Exp Immunol (2004) 0.93
Quantitative structure-activity studies on effects of sixteen different steroids on growth and monooxygenases of rat liver. Cancer Res (1988) 0.93
Search for compounds that inhibit the genotoxic and carcinogenic effects of heterocyclic aromatic amines. Crit Rev Toxicol (2000) 0.90
Apoptosis in the liver and its role in hepatocarcinogenesis. Cell Biol Toxicol (1997) 0.90
Levels of transforming growth factor beta and transforming growth factor beta receptors in rat liver during growth, regression by apoptosis and neoplasia. Hepatology (1998) 0.89
Peroxisome proliferators do not increase DNA synthesis in purified rat hepatocytes. Carcinogenesis (2001) 0.88
Growth, regression and cell death in rat liver as related to tissue levels of the hepatomitogen cyproterone acetate. Arch Toxicol (1986) 0.87
Apoptosis and multistage carcinogenesis in rat liver. Mutat Res (1995) 0.86
Two-stage control of cell proliferation induced in rat liver by alpha-hexachlorocyclohexane. Cancer Res (1977) 0.86
Quantitative analysis of tumor initiation in rat liver: role of cell replication and cell death (apoptosis). Carcinogenesis (2000) 0.86
New cellular tools reveal complex epithelial-mesenchymal interactions in hepatocarcinogenesis. Br J Cancer (2008) 0.85
Active cell death (apoptosis) in liver biology and disease. Prog Liver Dis (1995) 0.85
Cytoprotective effect of the prostacyclin derivative iloprost against liver cell death induced by the hepatotoxins carbon tetrachloride and bromobenzene. Klin Wochenschr (1986) 0.85
Kinetics of DNA synthesis in feeding-dependent and independent hepatocyte populations of rats after partial hepatectomy. Cell Tissue Kinet (1983) 0.85
Expression and dimerization of the rat activin subunits betaC and betaE: evidence for the ormation of novel activin dimers. J Mol Endocrinol (2002) 0.84
Toxicological studies on a benzofurane derivative. II. Demonstration of peroxisome proliferation in rat liver. Toxicol Appl Pharmacol (1990) 0.83
Feedback inhibition of hepatic DNA synthesis. Cell Tissue Kinet (1980) 0.83
The role of growth of normal and preneoplastic cell populations for tumor promotion in rat liver. Environ Health Perspect (1983) 0.83
Toxic effects of griseofulvin: disease models, mechanisms, and risk assessment. Crit Rev Toxicol (1997) 0.83
Initiation and promotion in hepatocarcinogenesis. Arch Toxicol (1987) 0.83
Inhibition of the genotoxic effects of heterocyclic amines in human derived hepatoma cells by dietary bioantimutagens. Mutagenesis (1997) 0.83
Coffee consumption protects human lymphocytes against oxidative and 3-amino-1-methyl-5H-pyrido[4,3-b]indole acetate (Trp-P-2) induced DNA-damage: results of an experimental study with human volunteers. Food Chem Toxicol (2007) 0.83
Adaptive responses of rat liver to the gestagen and anti-androgen cyproterone acetate and other inducers. III. Cytological changes. Chem Biol Interact (1980) 0.83
Induction of monooxygenases and growth in rat liver by progesterone. Arch Toxicol (1986) 0.83
Increased susceptibility of aged rats to hepatocarcinogenesis by the peroxisome proliferator nafenopin and the possible involvement of altered liver foci occurring spontaneously. Cancer Res (1991) 0.82
Control of cell death (apoptosis) by diethylstilbestrol in an estrogen-dependent kidney tumor. Carcinogenesis (1991) 0.82
Dose-response studies on the effects of alpha-, beta-, and gamma-hexachlorocyclohexane on putative preneoplastic foci, monooxygenases, and growth in rat liver. Cancer Res (1987) 0.82
Musk ketone enhances benzo(a)pyrene induced mutagenicity in human derived Hep G2 cells. Mutat Res (2001) 0.81
Active cell death: role in hepatocarcinogenesis and subtypes. Biochem Cell Biol (1995) 0.81
Benzalkonium chloride (BAC) and dimethyldioctadecyl-ammonium bromide (DDAB), two common quaternary ammonium compounds, cause genotoxic effects in mammalian and plant cells at environmentally relevant concentrations. Mutagenesis (2007) 0.81
Histochemical and biochemical studies on the effect of the prostacyclin derivative iloprost on CCl4-induced lipid peroxidation in rat liver and its significance for hepatoprotection. Hepatology (1989) 0.81
Effect of tumor promoting contraceptive steroids on growth and drug metabolizing enzymes in rat liver. Cancer Res (1986) 0.81
Suppression of apoptosis in C3H mouse liver tumors by activated Ha-ras oncogene. Carcinogenesis (2000) 0.80
The role of Foxp3+ T cells in long-term efficacy of prophylactic and therapeutic mucosal tolerance induction in mice. Allergy (2006) 0.80
Kinetics of apoptosis and secondary necrosis in cultured rat thymocytes and S.49 mouse lymphoma and CEM human leukemia cells. Biochem Cell Biol (1995) 0.80
Role of apoptosis for mouse liver growth regulation and tumor promotion: comparative analysis of mice with high (C3H/He) and low (C57Bl/6J) cancer susceptibility. Toxicol Lett (2004) 0.80
[Number and "ploidy" of liver cell nuclei under the influence of substances alien to the body. Analysis by means of an electronic particle counter]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1968) 0.80
Effects of hypolipidemic drugs nafenopin and clofibrate on phenotypic expression and cell death (apoptosis) in altered foci of rat liver. Carcinogenesis (1990) 0.79
Tumor promotion by the peroxisome proliferator nafenopin involving a specific subtype of altered foci in rat liver. Cancer Res (1990) 0.79
Expression of cytochrome P450 2A5 in preneoplastic and neoplastic mouse liver lesions. Mol Carcinog (1998) 0.79
Changes in liver fatty acid-binding protein in rat enzyme-altered foci. Cancer Lett (1998) 0.78
Facilitated expression of adaptive responses to phenobarbital in putative pre-stages of liver cancer. Carcinogenesis (1986) 0.78
Liver growth and mixed-function oxidase activity: dose-dependent stimulatory and inhibitory effects of alpha-hexachlorocyclohexane. Naunyn Schmiedebergs Arch Pharmacol (1974) 0.78
Genotoxic effects of heterocyclic aromatic amines in human derived hepatoma (HepG2) cells. Mutagenesis (1999) 0.78
Failure to demonstrate chemoprevention by the monoterpene perillyl alcohol during early rat hepatocarcinogenesis: a cautionary note. Carcinogenesis (2000) 0.78
Glutathione S-transferase isoenzyme patterns in different subtypes of enzyme-altered rat liver foci treated with the peroxisome proliferator nafenopin or with phenobarbital. Carcinogenesis (1993) 0.78
A recombinant allergen chimer as novel mucosal vaccine candidate for prevention of multi-sensitivities. Allergy (2007) 0.78
Growth kinetics of enzyme-altered liver foci in rats treated with phenobarbital or alpha-hexachlorocyclohexane. Toxicol Appl Pharmacol (1995) 0.78
Enhancement of peroxisomal enzymes, cytochrome P-452 and DNA synthesis in putative preneoplastic foci of rat liver treated with the peroxisome proliferator nafenopin. Carcinogenesis (1993) 0.78
Role of transforming growth factor alpha and prostaglandins in preferential growth of preneoplastic rat hepatocytes. Carcinogenesis (2001) 0.78